DOSIERUNGSSCHEMA VON GLP-1
European patent · EP4090351 · In force
Register entry
- Publication number
- EP4090351
- Application number
- EP20914010
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jan 16, 2020
- Published
- Nov 23, 2022
- Granted
- Mar 4, 2026
- Protection ends at the latest
- Jan 15, 2040
- Next annual fee due
- Jan 31, 2027
- IPC classes
- A61K 31/155 (2006.01)A61K 38/17 (2006.01)A61K 38/28 (2006.01)A61P 3/04 (2006.01)A61P 3/08 (2006.01)A61P 3/10 (2006.01)A61K 45/06 (2006.01)A61K 38/26 (2006.01)
- PCT application
- PCT/CN2020/072554 16.01.2020
- PCT publication
- WO2021/142736 22.07.2021
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Mar 4, 2026
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 04.03.2026
Parties
Inventor
SANG, Huiqing
Shanghai 201321, CN
LU, Hai
Shanghai 201321, CN
DU, Zhiqiang
Shanghai 201321, CN
FANG, Xiankang
Shanghai 201321, CN
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.